Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants.

Journal of human genetics - 1 Apr 2017

Tada Hayato, Kawashiri Masa-Aki, Yamagishi Masakazu

Abstract excerpt

Dyslipidemias, especially hyper-low-density lipoprotein cholesterolemia and hypertriglyceridemia, are important causal risk factors for coronary artery disease. Comprehensive genotyping using the 'next-generation sequencing' technique has facilitated the investigation of Mendelian dyslipidemias, in addition to Mendelian randomization studies using common genetic variants associated with plasma lipids and coronary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyslipidemias

Share to Genetic Variation

Share to High-Throughput Nucleotide Sequencing

Share to Lipids

Share to Randomized Controlled Trials as Topic

Share to Risk Factors

Source

Identifiers

PMID: 28055004
DOI: 10.1038/jhg.2016.159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants.PMID 28055004Read ↗

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.Semantic proximity Read ↗

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.Semantic proximity Read ↗

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery DiseaseSemantic proximity Read ↗

Targeted next-generation sequencing in monogenic dyslipidemias.Semantic proximity Read ↗

Mendelian randomization: Its impact on cardiovascular disease.Semantic proximity Read ↗

Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.Semantic proximity Read ↗

Distinct genetic architecture of coronary heart disease in dyslipidemia patients.Semantic proximity Read ↗

Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies.Semantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Semantic proximity Read ↗

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic StudiesSemantic proximity Read ↗

The association between lipid metabolism and coronary artery disease: A systematic Mendelian randomization study combined with transcriptome analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.